Last reviewed · How we verify
NCT05952791
Case Report in Complications After Laparoscopic Transabdominal Preperitoneal Groin Hernia Repair Using LiquiBandFIX8®
trial testing Surgery in Groin Hernia in 1 participant. Completed in 5 January 2022.
5 January 2022
Quick facts
| Lead sponsor | Kepler University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 5 January 2022 |
| Primary completion | 5 January 2022 |
| Estimated completion | 5 January 2022 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Surgery
Conditions studied
- Groin Hernia — all drugs for Groin Hernia →
Sponsor
Kepler University Hospital
Who can join
Eligibility, any sex, with Groin Hernia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This an a case report about management and proving the strenght and resistance of LiquiBandFIX8® using for peritoneal closure in a laparoscopic transabdominal preperitoneal groin hernia repair. The patient had anticoagulation due to a mechanical valvula and postoperatively the patient developed a huge hematoma extraperitoneally. Relaparoscopy war performed to identify the problem and check the peritoneal closure.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Laparoscopic transabdominal preperitoneal (TAPP) groin hernia repair using n-butyl-2-cyanoacrylate (LiquiBandFIX8) for mesh fixation and peritoneal closure: case report about extraperitoneal hematoma.
Raab S, Huber L, Fortelny R, Shamiyeh A. · · 2024 · cited 1× · PMID 38222725 · DOI 10.1097/ms9.0000000000001439
Verify or expand the search:
- PubMed search for NCT05952791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Surgery
Trials testing the same drug.
- NCT07472478 — Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12 · Phase 2 · not yet recruiting
- NCT07524452 — Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, · Phase 3 · recruiting
- NCT07053033 — Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR Be · Phase 2 · recruiting
- NCT07352007 — Sintilimab Combined With Stereotactic Body Radiotherapy as Neoadjuvant Therapy for Resectable Hepatocellular · Phase 2 · not yet recruiting
- NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting
Other recruiting trials for Groin Hernia
Currently open trials in the same condition.
- NCT06871605 — Transversalis Fascia Plane vs Ilioinguinal and Iliohypogastric Nerve Block for the Treatment of CPIP · NA · recruiting
- NCT06576154 — The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias · Phase 3 · recruiting
- NCT05934266 — Impact of Mesh Fixation With Tissue Adhesive · Phase 4 · active not recruiting
Other Kepler University Hospital trials
Trials by the same sponsor.
- NCT06030986 — Prediction of Outcome in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT06574906 — Machine Learning Prediction of Parameters of Early Warning Scores in General Wards · active not recruiting
- NCT07506005 — Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line · recruiting
- NCT06259812 — Machine Learning Prediction of Parameters of Early Warning Scores in Intensive Care Units · active not recruiting
- NCT05753995 — Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05952791 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kepler University Hospital
- Last refreshed: 19 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing